F-star Therapeutics logo

F-star Therapeutics FSTX

Quarterly report 2022-Q3
added 11-10-2022

report update icon

Country

usaUSA

IPO year

2016

Industry

-

Stock Exchange

NASDAQ CAPITAL

Shares

16.6 M

Market Cap[1]

$ 157 M

EBITDA (LTM)

$ -49.5 M

P/E (LTM)

-

P/S (LTM)

21.31

EPS (LTM)

-2.81

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.